##Tirumotecan
LightNews LightNews
oncodaily.bsky.social
Sacituzumab Tirumotecan Earns Approval in China in Pretreated Advanced TNBC

https://oncodaily.com/drugs/sacituzumab-193201

##AntibodyDrugConjugate ##Cancer ##ChinasNationalMedicalProductsAdministration ##NMPA ##OncoDaily ##Oncology ##Sacituzumab ##Tirumotecan
Sacituzumab Tirumotecan Earns Approval in China in Pretreated Advanced TNBC - OncoDaily
Sacituzumab Tirumotecan Earns Approval in China in Pretreated Advanced TNBC / antibody-drug conjugate, cancer, China's National Medical Products
oncodaily.com
December 3, 2024 at 9:01 AM